Editas Medicine

Home » Editas Medicine

Secondary

Editas Medicine

Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.

Symbol

EDIT

Last Closing Price
$27.29

Shares
1,900,000

Effective Date
December 6, 2017

Underwriters
Morgan Stanley

To view the prospectus for Editas Medicine, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253